Haven Homes Of Maple Plain Medicare and Medicaid Location: 4848 Gateway Blvd, Maple Plain, Minnesota 55359 Ratings: Phone: (763) 479-1993 |
News Archive
In a new study, those who had three to four aging signs - receding hairline at the temples, baldness at the head's crown, earlobe crease, or yellow fatty deposits around the eyelid (xanthelasmata) - had a 57 percent increased risk for heart attack and a 39 percent increased risk for heart disease.
Emergency bypass surgery or angioplasty procedures to counteract deadly complications that follow some heart attacks not only improve survival odds for cardiogenic shock patients, but the quality of life after such emergency revascularization procedures appears to be better than that of survivors who received less aggressive treatment, according to a new study in the July 19, 2005, issue of the Journal of the American College of Cardiology.
Savient Pharmaceuticals, Inc. announced the official full U.S. commercial launch of KRYSTEXXAâ„¢ (pegloticase), which has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic gout in adult patients refractory to conventional therapy. KRYSTEXXA is now the first and only therapy available to address this unmet medical need.
Top international health authorities are urging new efforts to bolster disease surveillance in the Americas, saying that small and poorer countries in the region have limited ability to detect, assess and report on disease outbreaks that could spread beyond their borders.
TechniScan, Inc., a medical device company engaged in the development and commercialization of an automated 3-D breast ultrasound imaging system, today announced that in collaboration with University Medical Center Freiburg in Germany, it has launched a clinical study to assess clinical utility of TechniScan's Warm Bath Ultrasound.
› Verified 7 days ago